Treatment resistant depression in elderly

Prog Brain Res. 2023:281:25-53. doi: 10.1016/bs.pbr.2023.02.004. Epub 2023 Mar 23.

Abstract

Treatment refractory depression (TRD) in the elderly is a common psychiatric disorder with high comorbidity and mortality. Older adults with TRD often have complicated comorbidities and several predisposing risk factors, which may lead to neuropsychiatric dysfunction and poor response to treatment. Several hypotheses suggest the underlying mechanisms, including vascular, immunological, senescence, or abnormal protein deposition. Treatment strategies for TRD include optimization of current medication dose, augmentation, switching to an alternative agent or class, and combination of different antidepressant classes, as well as nonpharmacological adjuvant interventions such as biophysical stimulation and psychotherapy. In summary, treatment recommendations for TRD in the elderly favor a multimodal approach, combining pharmacological and nonpharmacological treatments.

Keywords: Biophysical stimulation; Late-life depression; Neurodegeneration; Neuroinflammation; Pharmacological intervention; Psychotherapy; Treatment-resistant depression; White matter hyperintensities.

MeSH terms

  • Aged
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Treatment-Resistant* / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Psychotherapy
  • Treatment Outcome

Substances

  • Antidepressive Agents